Cross-Sector entity
Every one of those 1 sits in a single category, regulation. Thurman Rodgers is most often covered alongside Enphase Energy, which appears in 1 of these 1 story. Thurman Rodgers appears in 1 tracked Cross-Sector story from March 22, 2026.
1 verified story tracked
Last mentioned: Mar 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Thurman Rodgers is most often covered alongside Enphase Energy, which appears in 1 of these 1 story. Thurman Rodgers appears in 1 tracked Cross-Sector story from March 22, 2026. The tracked stories average 3 original sources each.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Thurman Rodgers. Shared-story counts are live from our verified record — not editorial picks.
Lead Plaintiff Deadline
Final date for investors to petition the court to lead the Enphase class action.
Litigation Expansion
Pomerantz confirms additional filings and alerts for Enphase and Nektar Therapeutics.
Insider Sale
Director Thurman Rodgers sells 137,250 shares of Enphase stock.
Initial Filing
Pomerantz LLP commences class action proceedings against Enphase Energy.
Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.
